Crown Laboratories Acquires Bellus Medical

October 12, 2018

Specialty pharmace­utical company Crown Laboratories, Inc. and portfolio company Hildred Capital Partners LLC (Hildred) have announced the acquisition of Bellus Medical.
Bellus Medical specializes in medical aesthetic treatments, delivering repairing and restorative products to aesthetic practices around the globe. Its range of products include SkinPen, a medical grade microneedling device used exclusively by healthcare providers to improve the appearance of facial acne scars.

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • The Beauty Health Company (SKIN) Rebrands to SkinHealth Systems
    • Amazon Launches GLP-1 Weight Loss Program with One Medical
    • Botox Cosmetic’s “The Confidence Collective” to Empower 250 Women Entrepreneurs
    • Medical Spa Show 2027 Call for Presentations Now Open
    • FDA Warning Letter to Texas Medical Spa Signals Increased Compliance Enforcement